Unicorn

Unicorn Biotechnologies is a UK-based biotechnology company focused on standardizing and scaling the manufacturing of cell-based therapies and regenerative medicines. The company's core technology, the Emmet platform, is an automated, benchtop cell culture system designed to replace manual tissue culture workflows with intelligent, self-driving laboratory processes. By integrating hardware and software, Unicorn Bio enables the autonomous expansion and differentiation of various cell types, including induced pluripotent stem cells (iPSCs), cardiomyocytes, and neuronal progenitors. Their mission is to reduce the high costs and variability associated with cell therapy production, facilitating the transition from research and development to large-scale clinical and commercial manufacturing.